NASDAQ
mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) mNEXSPIKE will be available in the...
Stock News Tech-led selloff caps tough week: US stocks fell as investors rotated out of mega-cap tech after Broadcom (AVGO) and Oracle (ORCL) stoked AI-spending...
FDA officials are weighing a black box warning for Covid vaccines, a proposal that has drawn strong criticism from outside experts citing lack of evidence....
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold' rating and $30 price target, implying limited upside, from Jefferies analysts in their initial coverage of the drugmaker. Moderna shares ...
Pre-Market Stock Futures: The futures are trading mixed as we get set to close out a wild and woolly week that saw a touch of just about everything. The Federal Reserve, as expected, cut rates again a...
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold’ rating and $30 price target, implying limited upside, from Jefferies analysts in their......
U.S. Global Investors (NASDAQ:GROW) announced that it will maintain its monthly dividend payments, with $0.0075 per share scheduled for January through......
Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs....
Amundi reduced its position in shares of Moderna, Inc. (NASDAQ: MRNA) by 31.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fi...
Moderna (MRNA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MRNA broke through the 50-day moving average, which suggests a short-...
No price data available for this timeframe.